Sveinung Hole

Med Storm Innovation AS develops bio sensor systems. It develops medical software solutions for analyzing skin conductance or emotional sweating for monitoring and detecting stress/pain and awakening on patients. The company was founded by Hanne Storm on December 22, 1998 and is headquartered in Oslo, Norway.

Isentio AS provides deoxyribonucleic acid analysis tools for pathogen identification. Its platform RipSeq can analyze both next-generation sequencing and Sanger direct-from-specimen sequencing files. Its product focuses on analyzing mixed clinical samples. The firm also has a pathogen database called Vivet. The company was founded by Oystein Friestad Saebo and Øyvind Kommedal in 2005 and is headquartered in Bergen, Norway.

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

Norsk Venturekapitalforening operates as a non-profit interest organization for active owner of funds within seed, venture, and acquisitions. The company was founded in 2001 and is headquartered in Oslo, Norway.

Nordic & Europe Health Invest AS target companies primarily from the Nordic Region, but will consider investments in other Northern Europe countries. It will invest between NOK 100 million and NOK 150 million in each company and will make follow-up investments. It seeks a controlling and non-majority stake position in firms with the health care sector such as pharmaceutical/nutraceuticals, diagnostics, novel products for lowering of health care spending, medical devices and healthcare providers. Occasionally it will invest up to 20 % in early stage companies.

PE Helse AS provides investment services. The private company is based in Oslo, Norway.

Sarsia Seed AS also known as Sarsia Seed Fund I invests in companies located in Norway. It focuses on enterprises specializing in the fields of biotechnology, life sciences, and marine technology. The fund provides financing for seed and early-stage capital requirements as well as participates in succeeding rounds.

SKGJ PE INVEST AS provides investment services. The private company is based in Blomsterdalen, Norway.

ICON CAPITAL VII AS is an investment firm. The private company is based in Oslo, Norway.